Article de Périodique
DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in France (2025)
Auteur(s) :
REVOL, B. ;
WILLEMAN, T. ;
MANCEAU, M. ;
DUMESTRE-TOULET, V. ;
GAULIER, J. M. ;
BOUCHER, A. ;
BERTIN, C. ;
EYSSERIC-GUÉRIN, H. ;
FOUILHE SAM-LAI, N. ;
Compagnie Nationale des Biologistes et Analystes Experts (CNBAE) ;
French Addictovigilance Network (FAN)
Année :
2025
Page(s) :
197-204
Langue(s) :
Anglais
Refs biblio. :
39
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
FRANCE
Thésaurus mots-clés
BASE DE DONNEES
;
ADDICTOVIGILANCE
;
MORTALITE
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
ANTALGIQUES
;
MEDICAMENTS
;
PRODUIT ILLICITE
;
NALOXONE
;
OPIOIDES
;
METHADONE
Organismes
ANSM
Résumé :
Introduction: The DRAMES (décès en relation avec l'abus de médicaments et de substances) registry is a French database of drug-related deaths (medications or illicit drugs) among drug users. The DTA (décès toxiques par antalgiques) registry is a French database of analgesic-related deaths among people without a history of drug abuse. Both registries are based on the collection of data on deaths for which forensic toxicology experts have performed analyses.
Material and methods: In the present study, we included drug- and analgesic-related deaths occurring from January 2013 to December 2022 in France. Subject demographic characteristics and medical history, forensic autopsy findings and toxicology reports were evaluated.
Results: Among drug users (DRAMES registry), opioids used alone or in combination were the main contributor to drug-related deaths in France, as they are in most countries. However, licit methadone was the leading cause of opioid-related deaths (ahead of heroin) during the study period. The main trend was the dramatic increase in cocaine-related mortality. Among medical users of analgesics (DTA registry), tramadol was the leading cause of deaths throughout this period.
Conclusion: A large-scale naloxone distribution program is urgently needed in France to prevent opioid overdoses, including among licit methadone users. However, our data do not support the hypothesis of an opioid crisis in France, although close monitoring is still required, particularly for oxycodone. [Author's abstract]
Material and methods: In the present study, we included drug- and analgesic-related deaths occurring from January 2013 to December 2022 in France. Subject demographic characteristics and medical history, forensic autopsy findings and toxicology reports were evaluated.
Results: Among drug users (DRAMES registry), opioids used alone or in combination were the main contributor to drug-related deaths in France, as they are in most countries. However, licit methadone was the leading cause of opioid-related deaths (ahead of heroin) during the study period. The main trend was the dramatic increase in cocaine-related mortality. Among medical users of analgesics (DTA registry), tramadol was the leading cause of deaths throughout this period.
Conclusion: A large-scale naloxone distribution program is urgently needed in France to prevent opioid overdoses, including among licit methadone users. However, our data do not support the hypothesis of an opioid crisis in France, although close monitoring is still required, particularly for oxycodone. [Author's abstract]
Affiliation :
Addictovigilance Dept, Grenoble-Alpes University Hospital, Grenoble, France